nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—Atorvastatin—coronary artery disease	0.393	1	CrCtD
Conivaptan—AVPR1A—coronary artery disease	0.205	1	CbGaD
Conivaptan—Atorvastatin—Pitavastatin—coronary artery disease	0.168	0.709	CrCrCtD
Conivaptan—Deferasirox—Telmisartan—coronary artery disease	0.0692	0.291	CrCrCtD
Conivaptan—CYP3A4—Ticagrelor—coronary artery disease	0.0116	0.146	CbGbCtD
Conivaptan—CYP3A4—Fenofibrate—coronary artery disease	0.0103	0.131	CbGbCtD
Conivaptan—CYP3A4—Gemfibrozil—coronary artery disease	0.00825	0.104	CbGbCtD
Conivaptan—CYP3A4—Clopidogrel—coronary artery disease	0.00715	0.0905	CbGbCtD
Conivaptan—CYP3A4—Eplerenone—coronary artery disease	0.00665	0.0841	CbGbCtD
Conivaptan—CYP3A4—Enalapril—coronary artery disease	0.00593	0.075	CbGbCtD
Conivaptan—CYP3A4—Ezetimibe—coronary artery disease	0.00461	0.0583	CbGbCtD
Conivaptan—CYP3A4—Rosuvastatin—coronary artery disease	0.00461	0.0583	CbGbCtD
Conivaptan—CYP3A4—Simvastatin—coronary artery disease	0.00429	0.0542	CbGbCtD
Conivaptan—CYP3A4—Pravastatin—coronary artery disease	0.00419	0.053	CbGbCtD
Conivaptan—CYP3A4—Lovastatin—coronary artery disease	0.00419	0.053	CbGbCtD
Conivaptan—CYP3A4—Atorvastatin—coronary artery disease	0.00382	0.0483	CbGbCtD
Conivaptan—CYP3A4—Losartan—coronary artery disease	0.00349	0.0442	CbGbCtD
Conivaptan—Tolvaptan—AVPR1A—coronary artery disease	0.000949	0.712	CrCbGaD
Conivaptan—Atorvastatin—HMGCR—coronary artery disease	0.000291	0.218	CrCbGaD
Conivaptan—Atorvastatin—CYP2C19—coronary artery disease	9.3e-05	0.0697	CrCbGaD
Conivaptan—Dry mouth—Captopril—coronary artery disease	5.59e-05	0.00115	CcSEcCtD
Conivaptan—Pain—Simvastatin—coronary artery disease	5.59e-05	0.00115	CcSEcCtD
Conivaptan—Constipation—Simvastatin—coronary artery disease	5.59e-05	0.00115	CcSEcCtD
Conivaptan—Insomnia—Valsartan—coronary artery disease	5.58e-05	0.00115	CcSEcCtD
Conivaptan—Skin disorder—Trandolapril—coronary artery disease	5.57e-05	0.00115	CcSEcCtD
Conivaptan—Nausea—Gemfibrozil—coronary artery disease	5.57e-05	0.00115	CcSEcCtD
Conivaptan—Body temperature increased—Clopidogrel—coronary artery disease	5.56e-05	0.00115	CcSEcCtD
Conivaptan—Insomnia—Olmesartan—coronary artery disease	5.56e-05	0.00115	CcSEcCtD
Conivaptan—Nervous system disorder—Telmisartan—coronary artery disease	5.53e-05	0.00114	CcSEcCtD
Conivaptan—Feeling abnormal—Eplerenone—coronary artery disease	5.53e-05	0.00114	CcSEcCtD
Conivaptan—Confusional state—Captopril—coronary artery disease	5.53e-05	0.00114	CcSEcCtD
Conivaptan—Body temperature increased—Lovastatin—coronary artery disease	5.52e-05	0.00114	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	5.51e-05	0.00114	CcSEcCtD
Conivaptan—Diarrhoea—Acetylsalicylic acid—coronary artery disease	5.48e-05	0.00113	CcSEcCtD
Conivaptan—Skin disorder—Telmisartan—coronary artery disease	5.48e-05	0.00113	CcSEcCtD
Conivaptan—Cardiac disorder—Timolol—coronary artery disease	5.47e-05	0.00113	CcSEcCtD
Conivaptan—Nausea—Ticagrelor—coronary artery disease	5.44e-05	0.00112	CcSEcCtD
Conivaptan—Mediastinal disorder—Ramipril—coronary artery disease	5.43e-05	0.00112	CcSEcCtD
Conivaptan—Dry mouth—Perindopril—coronary artery disease	5.43e-05	0.00112	CcSEcCtD
Conivaptan—Insomnia—Niacin—coronary artery disease	5.43e-05	0.00112	CcSEcCtD
Conivaptan—Body temperature increased—Ezetimibe—coronary artery disease	5.42e-05	0.00112	CcSEcCtD
Conivaptan—Urinary tract disorder—Lisinopril—coronary artery disease	5.4e-05	0.00111	CcSEcCtD
Conivaptan—Feeling abnormal—Simvastatin—coronary artery disease	5.39e-05	0.00111	CcSEcCtD
Conivaptan—Oedema peripheral—Lisinopril—coronary artery disease	5.38e-05	0.00111	CcSEcCtD
Conivaptan—Confusional state—Perindopril—coronary artery disease	5.37e-05	0.00111	CcSEcCtD
Conivaptan—Hypotension—Trandolapril—coronary artery disease	5.36e-05	0.00111	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	5.36e-05	0.00111	CcSEcCtD
Conivaptan—Urethral disorder—Lisinopril—coronary artery disease	5.36e-05	0.00111	CcSEcCtD
Conivaptan—Insomnia—Pravastatin—coronary artery disease	5.34e-05	0.0011	CcSEcCtD
Conivaptan—Angiopathy—Timolol—coronary artery disease	5.34e-05	0.0011	CcSEcCtD
Conivaptan—Hypotension—Enalapril—coronary artery disease	5.34e-05	0.0011	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Valsartan—coronary artery disease	5.33e-05	0.0011	CcSEcCtD
Conivaptan—Mediastinal disorder—Timolol—coronary artery disease	5.31e-05	0.0011	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Olmesartan—coronary artery disease	5.3e-05	0.00109	CcSEcCtD
Conivaptan—Body temperature increased—Eplerenone—coronary artery disease	5.3e-05	0.00109	CcSEcCtD
Conivaptan—Mental disorder—Ramipril—coronary artery disease	5.28e-05	0.00109	CcSEcCtD
Conivaptan—Dry mouth—Furosemide—coronary artery disease	5.28e-05	0.00109	CcSEcCtD
Conivaptan—Constipation—Valsartan—coronary artery disease	5.28e-05	0.00109	CcSEcCtD
Conivaptan—Hypotension—Telmisartan—coronary artery disease	5.27e-05	0.00109	CcSEcCtD
Conivaptan—Pain—Olmesartan—coronary artery disease	5.25e-05	0.00108	CcSEcCtD
Conivaptan—Constipation—Olmesartan—coronary artery disease	5.25e-05	0.00108	CcSEcCtD
Conivaptan—Erythema—Ramipril—coronary artery disease	5.25e-05	0.00108	CcSEcCtD
Conivaptan—Malnutrition—Ramipril—coronary artery disease	5.25e-05	0.00108	CcSEcCtD
Conivaptan—Nervous system disorder—Perindopril—coronary artery disease	5.22e-05	0.00108	CcSEcCtD
Conivaptan—Confusional state—Furosemide—coronary artery disease	5.22e-05	0.00108	CcSEcCtD
Conivaptan—Insomnia—Trandolapril—coronary artery disease	5.19e-05	0.00107	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Niacin—coronary artery disease	5.18e-05	0.00107	CcSEcCtD
Conivaptan—Skin disorder—Perindopril—coronary artery disease	5.17e-05	0.00107	CcSEcCtD
Conivaptan—Insomnia—Enalapril—coronary artery disease	5.17e-05	0.00107	CcSEcCtD
Conivaptan—Body temperature increased—Simvastatin—coronary artery disease	5.17e-05	0.00107	CcSEcCtD
Conivaptan—Headache—Rosuvastatin—coronary artery disease	5.17e-05	0.00107	CcSEcCtD
Conivaptan—Mental disorder—Timolol—coronary artery disease	5.16e-05	0.00107	CcSEcCtD
Conivaptan—Pain—Niacin—coronary artery disease	5.13e-05	0.00106	CcSEcCtD
Conivaptan—Erythema—Timolol—coronary artery disease	5.13e-05	0.00106	CcSEcCtD
Conivaptan—Malnutrition—Timolol—coronary artery disease	5.13e-05	0.00106	CcSEcCtD
Conivaptan—Hypotension—Captopril—coronary artery disease	5.12e-05	0.00106	CcSEcCtD
Conivaptan—Insomnia—Telmisartan—coronary artery disease	5.1e-05	0.00105	CcSEcCtD
Conivaptan—Vomiting—Acetylsalicylic acid—coronary artery disease	5.09e-05	0.00105	CcSEcCtD
Conivaptan—Dry mouth—Losartan—coronary artery disease	5.09e-05	0.00105	CcSEcCtD
Conivaptan—Nervous system disorder—Furosemide—coronary artery disease	5.07e-05	0.00105	CcSEcCtD
Conivaptan—Pruritus—Fenofibrate—coronary artery disease	5.06e-05	0.00105	CcSEcCtD
Conivaptan—Feeling abnormal—Olmesartan—coronary artery disease	5.06e-05	0.00105	CcSEcCtD
Conivaptan—Constipation—Pravastatin—coronary artery disease	5.05e-05	0.00104	CcSEcCtD
Conivaptan—Pain—Pravastatin—coronary artery disease	5.05e-05	0.00104	CcSEcCtD
Conivaptan—Confusional state—Losartan—coronary artery disease	5.03e-05	0.00104	CcSEcCtD
Conivaptan—Skin disorder—Furosemide—coronary artery disease	5.03e-05	0.00104	CcSEcCtD
Conivaptan—Pruritus—Clopidogrel—coronary artery disease	4.98e-05	0.00103	CcSEcCtD
Conivaptan—Hypotension—Perindopril—coronary artery disease	4.97e-05	0.00103	CcSEcCtD
Conivaptan—Infection—Losartan—coronary artery disease	4.96e-05	0.00102	CcSEcCtD
Conivaptan—Insomnia—Captopril—coronary artery disease	4.96e-05	0.00102	CcSEcCtD
Conivaptan—Angiopathy—Lisinopril—coronary artery disease	4.96e-05	0.00102	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Trandolapril—coronary artery disease	4.95e-05	0.00102	CcSEcCtD
Conivaptan—Pruritus—Lovastatin—coronary artery disease	4.94e-05	0.00102	CcSEcCtD
Conivaptan—Mediastinal disorder—Lisinopril—coronary artery disease	4.92e-05	0.00102	CcSEcCtD
Conivaptan—Constipation—Trandolapril—coronary artery disease	4.91e-05	0.00101	CcSEcCtD
Conivaptan—Nausea—Rosuvastatin—coronary artery disease	4.9e-05	0.00101	CcSEcCtD
Conivaptan—Diarrhoea—Fenofibrate—coronary artery disease	4.9e-05	0.00101	CcSEcCtD
Conivaptan—Nervous system disorder—Losartan—coronary artery disease	4.9e-05	0.00101	CcSEcCtD
Conivaptan—Constipation—Enalapril—coronary artery disease	4.89e-05	0.00101	CcSEcCtD
Conivaptan—Feeling abnormal—Pravastatin—coronary artery disease	4.87e-05	0.00101	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Telmisartan—coronary artery disease	4.87e-05	0.001	CcSEcCtD
Conivaptan—Body temperature increased—Olmesartan—coronary artery disease	4.86e-05	0.001	CcSEcCtD
Conivaptan—Pruritus—Ezetimibe—coronary artery disease	4.85e-05	0.001	CcSEcCtD
Conivaptan—Hypotension—Furosemide—coronary artery disease	4.83e-05	0.000998	CcSEcCtD
Conivaptan—Constipation—Telmisartan—coronary artery disease	4.82e-05	0.000995	CcSEcCtD
Conivaptan—Pain—Telmisartan—coronary artery disease	4.82e-05	0.000995	CcSEcCtD
Conivaptan—Insomnia—Perindopril—coronary artery disease	4.81e-05	0.000994	CcSEcCtD
Conivaptan—Diarrhoea—Clopidogrel—coronary artery disease	4.81e-05	0.000994	CcSEcCtD
Conivaptan—Mental disorder—Lisinopril—coronary artery disease	4.79e-05	0.000988	CcSEcCtD
Conivaptan—Diarrhoea—Lovastatin—coronary artery disease	4.78e-05	0.000987	CcSEcCtD
Conivaptan—Nausea—Acetylsalicylic acid—coronary artery disease	4.76e-05	0.000982	CcSEcCtD
Conivaptan—Erythema—Lisinopril—coronary artery disease	4.76e-05	0.000982	CcSEcCtD
Conivaptan—Malnutrition—Lisinopril—coronary artery disease	4.76e-05	0.000982	CcSEcCtD
Conivaptan—Pruritus—Eplerenone—coronary artery disease	4.75e-05	0.00098	CcSEcCtD
Conivaptan—Body temperature increased—Niacin—coronary artery disease	4.74e-05	0.00098	CcSEcCtD
Conivaptan—Feeling abnormal—Trandolapril—coronary artery disease	4.73e-05	0.000976	CcSEcCtD
Conivaptan—Feeling abnormal—Enalapril—coronary artery disease	4.71e-05	0.000972	CcSEcCtD
Conivaptan—Diarrhoea—Ezetimibe—coronary artery disease	4.69e-05	0.000968	CcSEcCtD
Conivaptan—Constipation—Captopril—coronary artery disease	4.69e-05	0.000968	CcSEcCtD
Conivaptan—Body temperature increased—Pravastatin—coronary artery disease	4.67e-05	0.000965	CcSEcCtD
Conivaptan—Hypotension—Losartan—coronary artery disease	4.66e-05	0.000963	CcSEcCtD
Conivaptan—Feeling abnormal—Telmisartan—coronary artery disease	4.65e-05	0.000959	CcSEcCtD
Conivaptan—Pruritus—Simvastatin—coronary artery disease	4.62e-05	0.000955	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Perindopril—coronary artery disease	4.6e-05	0.000949	CcSEcCtD
Conivaptan—Diarrhoea—Eplerenone—coronary artery disease	4.59e-05	0.000948	CcSEcCtD
Conivaptan—Constipation—Perindopril—coronary artery disease	4.55e-05	0.00094	CcSEcCtD
Conivaptan—Pain—Perindopril—coronary artery disease	4.55e-05	0.00094	CcSEcCtD
Conivaptan—Vomiting—Fenofibrate—coronary artery disease	4.55e-05	0.000939	CcSEcCtD
Conivaptan—Body temperature increased—Trandolapril—coronary artery disease	4.54e-05	0.000937	CcSEcCtD
Conivaptan—Body temperature increased—Enalapril—coronary artery disease	4.52e-05	0.000933	CcSEcCtD
Conivaptan—Feeling abnormal—Captopril—coronary artery disease	4.52e-05	0.000933	CcSEcCtD
Conivaptan—Insomnia—Losartan—coronary artery disease	4.52e-05	0.000932	CcSEcCtD
Conivaptan—Headache—Fenofibrate—coronary artery disease	4.48e-05	0.000926	CcSEcCtD
Conivaptan—Vomiting—Clopidogrel—coronary artery disease	4.47e-05	0.000923	CcSEcCtD
Conivaptan—Diarrhoea—Simvastatin—coronary artery disease	4.47e-05	0.000923	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Furosemide—coronary artery disease	4.47e-05	0.000922	CcSEcCtD
Conivaptan—Body temperature increased—Telmisartan—coronary artery disease	4.46e-05	0.00092	CcSEcCtD
Conivaptan—Vomiting—Lovastatin—coronary artery disease	4.44e-05	0.000917	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	4.43e-05	0.000916	CcSEcCtD
Conivaptan—Hypertension—Timolol—coronary artery disease	4.43e-05	0.000914	CcSEcCtD
Conivaptan—Pain—Furosemide—coronary artery disease	4.42e-05	0.000914	CcSEcCtD
Conivaptan—Constipation—Furosemide—coronary artery disease	4.42e-05	0.000914	CcSEcCtD
Conivaptan—Headache—Clopidogrel—coronary artery disease	4.41e-05	0.00091	CcSEcCtD
Conivaptan—Anaemia—Lisinopril—coronary artery disease	4.4e-05	0.000908	CcSEcCtD
Conivaptan—Feeling abnormal—Perindopril—coronary artery disease	4.39e-05	0.000906	CcSEcCtD
Conivaptan—Headache—Lovastatin—coronary artery disease	4.38e-05	0.000904	CcSEcCtD
Conivaptan—Pruritus—Valsartan—coronary artery disease	4.37e-05	0.000902	CcSEcCtD
Conivaptan—Dry mouth—Ramipril—coronary artery disease	4.37e-05	0.000902	CcSEcCtD
Conivaptan—Vomiting—Ezetimibe—coronary artery disease	4.36e-05	0.0009	CcSEcCtD
Conivaptan—Pruritus—Olmesartan—coronary artery disease	4.35e-05	0.000897	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	4.34e-05	0.000895	CcSEcCtD
Conivaptan—Body temperature increased—Captopril—coronary artery disease	4.33e-05	0.000895	CcSEcCtD
Conivaptan—Confusional state—Ramipril—coronary artery disease	4.32e-05	0.000891	CcSEcCtD
Conivaptan—Headache—Ezetimibe—coronary artery disease	4.29e-05	0.000887	CcSEcCtD
Conivaptan—Dry mouth—Timolol—coronary artery disease	4.27e-05	0.000881	CcSEcCtD
Conivaptan—Pain—Losartan—coronary artery disease	4.27e-05	0.000881	CcSEcCtD
Conivaptan—Constipation—Losartan—coronary artery disease	4.27e-05	0.000881	CcSEcCtD
Conivaptan—Vomiting—Eplerenone—coronary artery disease	4.27e-05	0.000881	CcSEcCtD
Conivaptan—Feeling abnormal—Furosemide—coronary artery disease	4.26e-05	0.00088	CcSEcCtD
Conivaptan—Nausea—Fenofibrate—coronary artery disease	4.25e-05	0.000878	CcSEcCtD
Conivaptan—Pruritus—Niacin—coronary artery disease	4.25e-05	0.000877	CcSEcCtD
Conivaptan—Diarrhoea—Valsartan—coronary artery disease	4.22e-05	0.000872	CcSEcCtD
Conivaptan—Confusional state—Timolol—coronary artery disease	4.22e-05	0.000871	CcSEcCtD
Conivaptan—Body temperature increased—Perindopril—coronary artery disease	4.21e-05	0.000869	CcSEcCtD
Conivaptan—Diarrhoea—Olmesartan—coronary artery disease	4.2e-05	0.000868	CcSEcCtD
Conivaptan—Headache—Eplerenone—coronary artery disease	4.2e-05	0.000868	CcSEcCtD
Conivaptan—Nervous system disorder—Ramipril—coronary artery disease	4.2e-05	0.000867	CcSEcCtD
Conivaptan—Pruritus—Pravastatin—coronary artery disease	4.18e-05	0.000863	CcSEcCtD
Conivaptan—Nausea—Clopidogrel—coronary artery disease	4.18e-05	0.000863	CcSEcCtD
Conivaptan—Skin disorder—Ramipril—coronary artery disease	4.16e-05	0.000858	CcSEcCtD
Conivaptan—Infection—Timolol—coronary artery disease	4.16e-05	0.000858	CcSEcCtD
Conivaptan—Vomiting—Simvastatin—coronary artery disease	4.16e-05	0.000858	CcSEcCtD
Conivaptan—Nausea—Lovastatin—coronary artery disease	4.15e-05	0.000857	CcSEcCtD
Conivaptan—Feeling abnormal—Losartan—coronary artery disease	4.11e-05	0.000849	CcSEcCtD
Conivaptan—Diarrhoea—Niacin—coronary artery disease	4.11e-05	0.000848	CcSEcCtD
Conivaptan—Nervous system disorder—Timolol—coronary artery disease	4.1e-05	0.000847	CcSEcCtD
Conivaptan—Headache—Simvastatin—coronary artery disease	4.09e-05	0.000845	CcSEcCtD
Conivaptan—Body temperature increased—Furosemide—coronary artery disease	4.09e-05	0.000844	CcSEcCtD
Conivaptan—Nausea—Ezetimibe—coronary artery disease	4.07e-05	0.000841	CcSEcCtD
Conivaptan—Skin disorder—Timolol—coronary artery disease	4.06e-05	0.000839	CcSEcCtD
Conivaptan—Pruritus—Trandolapril—coronary artery disease	4.06e-05	0.000838	CcSEcCtD
Conivaptan—Pruritus—Enalapril—coronary artery disease	4.04e-05	0.000835	CcSEcCtD
Conivaptan—Diarrhoea—Pravastatin—coronary artery disease	4.04e-05	0.000835	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	4.02e-05	0.00083	CcSEcCtD
Conivaptan—Hypotension—Ramipril—coronary artery disease	4e-05	0.000826	CcSEcCtD
Conivaptan—Pruritus—Telmisartan—coronary artery disease	3.99e-05	0.000823	CcSEcCtD
Conivaptan—Nausea—Eplerenone—coronary artery disease	3.98e-05	0.000823	CcSEcCtD
Conivaptan—Dry mouth—Lisinopril—coronary artery disease	3.96e-05	0.000818	CcSEcCtD
Conivaptan—Body temperature increased—Losartan—coronary artery disease	3.95e-05	0.000815	CcSEcCtD
Conivaptan—Diarrhoea—Trandolapril—coronary artery disease	3.93e-05	0.000811	CcSEcCtD
Conivaptan—Vomiting—Valsartan—coronary artery disease	3.92e-05	0.00081	CcSEcCtD
Conivaptan—Confusional state—Lisinopril—coronary artery disease	3.91e-05	0.000808	CcSEcCtD
Conivaptan—Diarrhoea—Enalapril—coronary artery disease	3.91e-05	0.000807	CcSEcCtD
Conivaptan—Hypotension—Timolol—coronary artery disease	3.91e-05	0.000807	CcSEcCtD
Conivaptan—Vomiting—Olmesartan—coronary artery disease	3.91e-05	0.000806	CcSEcCtD
Conivaptan—Nausea—Simvastatin—coronary artery disease	3.88e-05	0.000802	CcSEcCtD
Conivaptan—Pruritus—Captopril—coronary artery disease	3.88e-05	0.000801	CcSEcCtD
Conivaptan—Insomnia—Ramipril—coronary artery disease	3.87e-05	0.000799	CcSEcCtD
Conivaptan—Headache—Valsartan—coronary artery disease	3.87e-05	0.000798	CcSEcCtD
Conivaptan—Diarrhoea—Telmisartan—coronary artery disease	3.86e-05	0.000796	CcSEcCtD
Conivaptan—Infection—Lisinopril—coronary artery disease	3.86e-05	0.000796	CcSEcCtD
Conivaptan—Headache—Olmesartan—coronary artery disease	3.85e-05	0.000795	CcSEcCtD
Conivaptan—Vomiting—Niacin—coronary artery disease	3.82e-05	0.000788	CcSEcCtD
Conivaptan—Insomnia—Timolol—coronary artery disease	3.79e-05	0.000781	CcSEcCtD
Conivaptan—Skin disorder—Lisinopril—coronary artery disease	3.77e-05	0.000779	CcSEcCtD
Conivaptan—Pruritus—Perindopril—coronary artery disease	3.77e-05	0.000777	CcSEcCtD
Conivaptan—Headache—Niacin—coronary artery disease	3.76e-05	0.000776	CcSEcCtD
Conivaptan—Vomiting—Pravastatin—coronary artery disease	3.76e-05	0.000776	CcSEcCtD
Conivaptan—Diarrhoea—Captopril—coronary artery disease	3.75e-05	0.000774	CcSEcCtD
Conivaptan—Headache—Pravastatin—coronary artery disease	3.7e-05	0.000764	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Ramipril—coronary artery disease	3.7e-05	0.000763	CcSEcCtD
Conivaptan—Nausea—Valsartan—coronary artery disease	3.67e-05	0.000757	CcSEcCtD
Conivaptan—Pruritus—Furosemide—coronary artery disease	3.66e-05	0.000756	CcSEcCtD
Conivaptan—Constipation—Ramipril—coronary artery disease	3.66e-05	0.000756	CcSEcCtD
Conivaptan—Nausea—Olmesartan—coronary artery disease	3.65e-05	0.000753	CcSEcCtD
Conivaptan—Vomiting—Trandolapril—coronary artery disease	3.65e-05	0.000753	CcSEcCtD
Conivaptan—Diarrhoea—Perindopril—coronary artery disease	3.64e-05	0.000752	CcSEcCtD
Conivaptan—Vomiting—Enalapril—coronary artery disease	3.63e-05	0.00075	CcSEcCtD
Conivaptan—Hypotension—Lisinopril—coronary artery disease	3.63e-05	0.000749	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Timolol—coronary artery disease	3.61e-05	0.000746	CcSEcCtD
Conivaptan—Headache—Trandolapril—coronary artery disease	3.6e-05	0.000742	CcSEcCtD
Conivaptan—Vomiting—Telmisartan—coronary artery disease	3.58e-05	0.00074	CcSEcCtD
Conivaptan—Headache—Enalapril—coronary artery disease	3.58e-05	0.000739	CcSEcCtD
Conivaptan—Pain—Timolol—coronary artery disease	3.58e-05	0.000739	CcSEcCtD
Conivaptan—Nausea—Niacin—coronary artery disease	3.57e-05	0.000736	CcSEcCtD
Conivaptan—Diarrhoea—Furosemide—coronary artery disease	3.54e-05	0.000731	CcSEcCtD
Conivaptan—Pruritus—Losartan—coronary artery disease	3.53e-05	0.000729	CcSEcCtD
Conivaptan—Headache—Telmisartan—coronary artery disease	3.53e-05	0.000729	CcSEcCtD
Conivaptan—Feeling abnormal—Ramipril—coronary artery disease	3.53e-05	0.000728	CcSEcCtD
Conivaptan—Insomnia—Lisinopril—coronary artery disease	3.51e-05	0.000725	CcSEcCtD
Conivaptan—Nausea—Pravastatin—coronary artery disease	3.51e-05	0.000725	CcSEcCtD
Conivaptan—Vomiting—Captopril—coronary artery disease	3.49e-05	0.00072	CcSEcCtD
Conivaptan—Feeling abnormal—Timolol—coronary artery disease	3.45e-05	0.000712	CcSEcCtD
Conivaptan—Headache—Captopril—coronary artery disease	3.43e-05	0.000709	CcSEcCtD
Conivaptan—Diarrhoea—Losartan—coronary artery disease	3.42e-05	0.000705	CcSEcCtD
Conivaptan—Nausea—Trandolapril—coronary artery disease	3.41e-05	0.000704	CcSEcCtD
Conivaptan—Nausea—Enalapril—coronary artery disease	3.4e-05	0.000701	CcSEcCtD
Conivaptan—Vomiting—Perindopril—coronary artery disease	3.38e-05	0.000699	CcSEcCtD
Conivaptan—Body temperature increased—Ramipril—coronary artery disease	3.38e-05	0.000699	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.35e-05	0.000692	CcSEcCtD
Conivaptan—Nausea—Telmisartan—coronary artery disease	3.35e-05	0.000691	CcSEcCtD
Conivaptan—Headache—Perindopril—coronary artery disease	3.33e-05	0.000688	CcSEcCtD
Conivaptan—Constipation—Lisinopril—coronary artery disease	3.32e-05	0.000685	CcSEcCtD
Conivaptan—Pain—Lisinopril—coronary artery disease	3.32e-05	0.000685	CcSEcCtD
Conivaptan—Body temperature increased—Timolol—coronary artery disease	3.31e-05	0.000683	CcSEcCtD
Conivaptan—Vomiting—Furosemide—coronary artery disease	3.29e-05	0.000679	CcSEcCtD
Conivaptan—Nausea—Captopril—coronary artery disease	3.26e-05	0.000672	CcSEcCtD
Conivaptan—Headache—Furosemide—coronary artery disease	3.24e-05	0.000669	CcSEcCtD
Conivaptan—Feeling abnormal—Lisinopril—coronary artery disease	3.2e-05	0.000661	CcSEcCtD
Conivaptan—Vomiting—Losartan—coronary artery disease	3.17e-05	0.000655	CcSEcCtD
Conivaptan—Nausea—Perindopril—coronary artery disease	3.16e-05	0.000653	CcSEcCtD
Conivaptan—Headache—Losartan—coronary artery disease	3.13e-05	0.000646	CcSEcCtD
Conivaptan—Nausea—Furosemide—coronary artery disease	3.07e-05	0.000635	CcSEcCtD
Conivaptan—Body temperature increased—Lisinopril—coronary artery disease	3.07e-05	0.000634	CcSEcCtD
Conivaptan—Pruritus—Ramipril—coronary artery disease	3.03e-05	0.000625	CcSEcCtD
Conivaptan—Nausea—Losartan—coronary artery disease	2.97e-05	0.000612	CcSEcCtD
Conivaptan—Pruritus—Timolol—coronary artery disease	2.96e-05	0.000611	CcSEcCtD
Conivaptan—Diarrhoea—Ramipril—coronary artery disease	2.93e-05	0.000605	CcSEcCtD
Conivaptan—Diarrhoea—Timolol—coronary artery disease	2.86e-05	0.000591	CcSEcCtD
Conivaptan—Pruritus—Lisinopril—coronary artery disease	2.75e-05	0.000567	CcSEcCtD
Conivaptan—Vomiting—Ramipril—coronary artery disease	2.72e-05	0.000562	CcSEcCtD
Conivaptan—Headache—Ramipril—coronary artery disease	2.68e-05	0.000554	CcSEcCtD
Conivaptan—Vomiting—Timolol—coronary artery disease	2.66e-05	0.000549	CcSEcCtD
Conivaptan—Diarrhoea—Lisinopril—coronary artery disease	2.66e-05	0.000548	CcSEcCtD
Conivaptan—Headache—Timolol—coronary artery disease	2.62e-05	0.000541	CcSEcCtD
Conivaptan—Nausea—Ramipril—coronary artery disease	2.54e-05	0.000525	CcSEcCtD
Conivaptan—Nausea—Timolol—coronary artery disease	2.49e-05	0.000513	CcSEcCtD
Conivaptan—Vomiting—Lisinopril—coronary artery disease	2.47e-05	0.00051	CcSEcCtD
Conivaptan—Headache—Lisinopril—coronary artery disease	2.43e-05	0.000502	CcSEcCtD
Conivaptan—Nausea—Lisinopril—coronary artery disease	2.31e-05	0.000476	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CREB1—coronary artery disease	8.17e-06	0.000226	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGTR1—coronary artery disease	8.15e-06	0.000225	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—coronary artery disease	8.05e-06	0.000223	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6R—coronary artery disease	8.03e-06	0.000222	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL10—coronary artery disease	8.02e-06	0.000222	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLG—coronary artery disease	8e-06	0.000221	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—coronary artery disease	7.99e-06	0.000221	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6R—coronary artery disease	7.97e-06	0.00022	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL10—coronary artery disease	7.96e-06	0.00022	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLG—coronary artery disease	7.94e-06	0.000219	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB2—coronary artery disease	7.79e-06	0.000215	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB2—coronary artery disease	7.73e-06	0.000214	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCE—coronary artery disease	7.69e-06	0.000212	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—JAK2—coronary artery disease	7.68e-06	0.000212	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SOCS1—coronary artery disease	7.67e-06	0.000212	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—S100B—coronary artery disease	7.65e-06	0.000211	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCE—coronary artery disease	7.63e-06	0.000211	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—JAK2—coronary artery disease	7.63e-06	0.000211	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SOCS1—coronary artery disease	7.61e-06	0.00021	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—S100B—coronary artery disease	7.59e-06	0.00021	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SOCS3—coronary artery disease	7.57e-06	0.000209	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SOCS3—coronary artery disease	7.52e-06	0.000208	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KITLG—coronary artery disease	7.48e-06	0.000207	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFBR2—coronary artery disease	7.48e-06	0.000207	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	7.46e-06	0.000206	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KITLG—coronary artery disease	7.43e-06	0.000205	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFBR2—coronary artery disease	7.43e-06	0.000205	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP3—coronary artery disease	7.31e-06	0.000202	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT5A—coronary artery disease	7.31e-06	0.000202	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT5A—coronary artery disease	7.26e-06	0.000201	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP3—coronary artery disease	7.26e-06	0.000201	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOB—coronary artery disease	7.07e-06	0.000195	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOB—coronary artery disease	7.02e-06	0.000194	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL8—coronary artery disease	7.01e-06	0.000194	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—JAK2—coronary artery disease	6.97e-06	0.000193	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—coronary artery disease	6.96e-06	0.000192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDN1—coronary artery disease	6.96e-06	0.000192	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—JAK2—coronary artery disease	6.92e-06	0.000191	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDN1—coronary artery disease	6.91e-06	0.000191	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL5—coronary artery disease	6.9e-06	0.000191	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL5—coronary artery disease	6.85e-06	0.000189	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CSF2—coronary artery disease	6.8e-06	0.000188	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGF1—coronary artery disease	6.8e-06	0.000188	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GGT1—coronary artery disease	6.79e-06	0.000188	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CSF2—coronary artery disease	6.75e-06	0.000187	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF1—coronary artery disease	6.75e-06	0.000187	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LPL—coronary artery disease	6.75e-06	0.000187	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LPL—coronary artery disease	6.7e-06	0.000185	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RPS6KB1—coronary artery disease	6.69e-06	0.000185	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MEF2C—coronary artery disease	6.69e-06	0.000185	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MEF2C—coronary artery disease	6.64e-06	0.000184	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RPS6KB1—coronary artery disease	6.64e-06	0.000184	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ITGB3—coronary artery disease	6.52e-06	0.00018	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ITGB3—coronary artery disease	6.47e-06	0.000179	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—coronary artery disease	6.37e-06	0.000176	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PPP2CA—coronary artery disease	6.33e-06	0.000175	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—coronary artery disease	6.32e-06	0.000175	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PPP2CA—coronary artery disease	6.29e-06	0.000174	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCD—coronary artery disease	6.22e-06	0.000172	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCD—coronary artery disease	6.18e-06	0.000171	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA5B—coronary artery disease	6.17e-06	0.00017	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	6.1e-06	0.000169	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2A—coronary artery disease	6.09e-06	0.000168	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—C3—coronary artery disease	6.08e-06	0.000168	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2A—coronary artery disease	6.04e-06	0.000167	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—C3—coronary artery disease	6.03e-06	0.000167	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	6.01e-06	0.000166	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HIF1A—coronary artery disease	5.8e-06	0.00016	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGT—coronary artery disease	5.78e-06	0.00016	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HIF1A—coronary artery disease	5.75e-06	0.000159	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGT—coronary artery disease	5.73e-06	0.000158	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—coronary artery disease	5.66e-06	0.000156	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—coronary artery disease	5.66e-06	0.000156	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—coronary artery disease	5.62e-06	0.000155	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—coronary artery disease	5.62e-06	0.000155	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	5.6e-06	0.000155	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA1—coronary artery disease	5.59e-06	0.000155	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA1—coronary artery disease	5.55e-06	0.000153	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KDR—coronary artery disease	5.54e-06	0.000153	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	5.53e-06	0.000153	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK14—coronary artery disease	5.51e-06	0.000152	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KDR—coronary artery disease	5.5e-06	0.000152	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK14—coronary artery disease	5.47e-06	0.000151	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ESR1—coronary artery disease	5.4e-06	0.000149	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ESR1—coronary artery disease	5.36e-06	0.000148	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—F2—coronary artery disease	5.34e-06	0.000147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FN1—coronary artery disease	5.34e-06	0.000147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6ST—coronary artery disease	5.31e-06	0.000147	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—F2—coronary artery disease	5.3e-06	0.000146	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FN1—coronary artery disease	5.3e-06	0.000146	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6ST—coronary artery disease	5.28e-06	0.000146	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKBIA—coronary artery disease	5.27e-06	0.000146	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CKMT1B—coronary artery disease	5.24e-06	0.000145	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKBIA—coronary artery disease	5.24e-06	0.000145	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KIT—coronary artery disease	5.11e-06	0.000141	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KIT—coronary artery disease	5.07e-06	0.00014	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GSK3B—coronary artery disease	4.9e-06	0.000135	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GSK3B—coronary artery disease	4.87e-06	0.000134	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—coronary artery disease	4.86e-06	0.000134	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CREB1—coronary artery disease	4.86e-06	0.000134	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—coronary artery disease	4.83e-06	0.000133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CREB1—coronary artery disease	4.83e-06	0.000133	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—coronary artery disease	4.76e-06	0.000131	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6R—coronary artery disease	4.74e-06	0.000131	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—coronary artery disease	4.72e-06	0.000131	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6R—coronary artery disease	4.71e-06	0.00013	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—coronary artery disease	4.68e-06	0.000129	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAPK1—coronary artery disease	4.65e-06	0.000129	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—coronary artery disease	4.64e-06	0.000128	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAPK1—coronary artery disease	4.62e-06	0.000128	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.45e-06	0.000123	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—coronary artery disease	4.44e-06	0.000123	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.41e-06	0.000122	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—coronary artery disease	4.41e-06	0.000122	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGF2—coronary artery disease	4.3e-06	0.000119	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	4.27e-06	0.000118	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPAP2B—coronary artery disease	4.27e-06	0.000118	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CKM—coronary artery disease	4.27e-06	0.000118	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF2—coronary artery disease	4.27e-06	0.000118	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—coronary artery disease	4.24e-06	0.000117	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—coronary artery disease	4.21e-06	0.000116	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JAK2—coronary artery disease	4.12e-06	0.000114	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JAK2—coronary artery disease	4.09e-06	0.000113	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CA—coronary artery disease	4.04e-06	0.000112	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CA—coronary artery disease	4.01e-06	0.000111	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SULT4A1—coronary artery disease	3.97e-06	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	3.97e-06	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PYGM—coronary artery disease	3.97e-06	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PDK4—coronary artery disease	3.97e-06	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CKMT2—coronary artery disease	3.97e-06	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—coronary artery disease	3.96e-06	0.000109	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—coronary artery disease	3.76e-06	0.000104	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—coronary artery disease	3.73e-06	0.000103	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—coronary artery disease	3.63e-06	0.0001	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—coronary artery disease	3.61e-06	9.97e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP3—coronary artery disease	3.6e-06	9.95e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—coronary artery disease	3.58e-06	9.88e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP3—coronary artery disease	3.57e-06	9.88e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—coronary artery disease	3.55e-06	9.81e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GK—coronary artery disease	3.54e-06	9.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMGCS2—coronary artery disease	3.54e-06	9.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GYG1—coronary artery disease	3.54e-06	9.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PFKM—coronary artery disease	3.54e-06	9.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LDHA—coronary artery disease	3.54e-06	9.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GATM—coronary artery disease	3.54e-06	9.79e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCND1—coronary artery disease	3.5e-06	9.68e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCND1—coronary artery disease	3.48e-06	9.61e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—coronary artery disease	3.4e-06	9.4e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AK1—coronary artery disease	3.38e-06	9.34e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCH1—coronary artery disease	3.38e-06	9.34e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—coronary artery disease	3.38e-06	9.33e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—coronary artery disease	3.3e-06	9.12e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—coronary artery disease	3.28e-06	9.05e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MDH2—coronary artery disease	3.24e-06	8.95e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPAT—coronary artery disease	3.24e-06	8.95e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UGCG—coronary artery disease	3.24e-06	8.95e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLCD1—coronary artery disease	3.24e-06	8.95e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PGM1—coronary artery disease	3.12e-06	8.62e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—coronary artery disease	3.05e-06	8.44e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—coronary artery disease	3.03e-06	8.38e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PYGB—coronary artery disease	3.01e-06	8.32e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CKB—coronary artery disease	3.01e-06	8.32e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DLAT—coronary artery disease	2.83e-06	7.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLIN1—coronary artery disease	2.83e-06	7.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COX5B—coronary artery disease	2.83e-06	7.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PFKFB3—coronary artery disease	2.83e-06	7.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM2—coronary artery disease	2.83e-06	7.83e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—coronary artery disease	2.8e-06	7.75e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—coronary artery disease	2.78e-06	7.69e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK1—coronary artery disease	2.75e-06	7.6e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK1—coronary artery disease	2.73e-06	7.54e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SULT1E1—coronary artery disease	2.68e-06	7.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKR1B1—coronary artery disease	2.56e-06	7.08e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HK2—coronary artery disease	2.56e-06	7.08e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC27A1—coronary artery disease	2.45e-06	6.78e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LCAT—coronary artery disease	2.41e-06	6.65e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CPT1B—coronary artery disease	2.41e-06	6.65e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CA—coronary artery disease	2.39e-06	6.59e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CA—coronary artery disease	2.37e-06	6.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA4—coronary artery disease	2.36e-06	6.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PDHA1—coronary artery disease	2.28e-06	6.31e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCLM—coronary artery disease	2.28e-06	6.31e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2.21e-06	6.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2.21e-06	6.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.18e-06	6.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.15e-06	5.93e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HADH—coronary artery disease	2.15e-06	5.93e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—coronary artery disease	2.11e-06	5.84e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—coronary artery disease	2.1e-06	5.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX2—coronary artery disease	2.03e-06	5.62e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA2—coronary artery disease	2.03e-06	5.62e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.03e-06	5.62e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.01e-06	5.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX4—coronary artery disease	2.01e-06	5.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.01e-06	5.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HK1—coronary artery disease	2.01e-06	5.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HADHA—coronary artery disease	1.99e-06	5.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.96e-06	5.42e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—coronary artery disease	1.95e-06	5.39e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPA—coronary artery disease	1.94e-06	5.36e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—coronary artery disease	1.93e-06	5.35e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.88e-06	5.19e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA5—coronary artery disease	1.86e-06	5.14e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—P4HB—coronary artery disease	1.82e-06	5.04e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.79e-06	4.95e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—VCAN—coronary artery disease	1.69e-06	4.67e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.67e-06	4.63e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DCN—coronary artery disease	1.63e-06	4.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.58e-06	4.37e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HBA1—coronary artery disease	1.54e-06	4.26e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LIPC—coronary artery disease	1.54e-06	4.26e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.54e-06	4.26e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.54e-06	4.26e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOC3—coronary artery disease	1.53e-06	4.23e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LDLR—coronary artery disease	1.52e-06	4.21e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.5e-06	4.16e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.5e-06	4.16e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCLC—coronary artery disease	1.49e-06	4.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CETP—coronary artery disease	1.49e-06	4.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SDC1—coronary artery disease	1.47e-06	4.06e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.39e-06	3.84e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.39e-06	3.84e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CTGF—coronary artery disease	1.36e-06	3.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GOT2—coronary artery disease	1.34e-06	3.72e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.34e-06	3.72e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.24e-06	3.42e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.2e-06	3.31e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GOT1—coronary artery disease	1.16e-06	3.21e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GGT1—coronary artery disease	1.16e-06	3.21e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.04e-06	2.88e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.03e-06	2.86e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.03e-06	2.84e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAT—coronary artery disease	1.01e-06	2.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOB—coronary artery disease	9.85e-07	2.72e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—coronary artery disease	9.58e-07	2.65e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPL—coronary artery disease	9.41e-07	2.6e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX1—coronary artery disease	9.18e-07	2.54e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CD36—coronary artery disease	8.94e-07	2.47e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.83e-07	2.44e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—coronary artery disease	8.47e-07	2.34e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AGT—coronary artery disease	8.05e-07	2.22e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—coronary artery disease	7.89e-07	2.18e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA1—coronary artery disease	7.79e-07	2.15e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—coronary artery disease	6.87e-07	1.9e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—coronary artery disease	6.77e-07	1.87e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—coronary artery disease	6.18e-07	1.71e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—coronary artery disease	5.91e-07	1.63e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.4e-07	1.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.32e-07	9.19e-06	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—coronary artery disease	2.72e-07	7.51e-06	CbGpPWpGaD
